Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation
Ryota Kurimoto(Chiba University), Yuichi Takiguchi(Chiba University)
Cited by 70